Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes

Phytomedicine

Volumn 15, Issue 5, 2008, Pages 340-347

  Kim, Sangmin ^a,b,c   Kim, Yoonkyung ^a,b,c   Kim, Ji Eun ^a,b,c   Cho, Kwang Hyun ^a,b,c   Chung, Jin Ho ^a,b,c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Berberine; IL 6; Keratinocytes; MMP 9 (metalloproteinase 9); TPA

Indexed keywords

BERBERINE; COLLAGEN; GELATINASE B; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 3; SCLEROPROTEIN; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR AP 1;

AGING; ARTICLE; CUTANEOUS PARAMETERS; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SKIN INFLAMMATION; ULTRAVIOLET RADIATION;

BERBERINE; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; KERATINOCYTES; MATRIX METALLOPROTEINASE 9; MOLECULAR STRUCTURE; PYRIDINES;

EID: 41949120203     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2007.09.011     Document Type: Article

References (33)

1. Anis K.V., Rajeshkumar N.V., and Kuttan R. Inhibition of chemical carcinogenesis by berberine in rats and mice. J. Pharm. Pharmacol. 53 5 (2001) 763-768
2. Baccam M., Woo S.Y., Vinson C., and Bishop G.A. CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C/EBP. J. Immunol. 170 6 (2003) 3099-3108
3. Beetz A., Peter R.U., Oppel T., Kaffenberger W., Rupec R.A., Meyer M., van Beuningen D., Kind P., and Messer G. NF-kappaB and AP-1 are responsible for inducibility of the IL-6 promoter by ionizing radiation in HeLa cells. Int. J. Radiat. Biol. 76 11 (2000) 1443-1453
4. Brenneisen P., Wlaschek M., Wenk J., Blaudschun R., Hinrichs R., Dissemond J., Krieg T., and Scharffetter-Kochanek K. Ultraviolet-B induction of interstitial collagenase and stromelyin-1 occurs in human dermal fibroblasts via an autocrine interleukin-6-dependent loop. FEBS Lett. 449 1 (1999) 36-40
5. Chen W., and Bowden G.T. Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes. Oncogene 18 52 (1999) 7469-7476
6. Chi C.W., Chang Y.F., Chao T.W., Chiang S.H., P'Eng F.K., Lui W.Y., and Liu T.Y. Flowcytometric analysis of the effect of berberine on the expression of glucocorticoid receptors in human hepatoma HepG2 cells. Life Sci. 54 26 (1994) 2099-2107
7. Chung J.H., Youn S.H., Koh W.S., Eun H.C., Cho K.H., Park K.C., and Youn J.I. Ultraviolet B irradiation-enhanced interleukin (IL)-6 production and mRNA expression are mediated by IL-1 alpha in cultured human keratinocytes. J. Invest. Dermatol. 106 4 (1996) 715-720
8. Chung T.D., Yu J.J., Kong T.A., Spiotto M.T., and Lin J.M. Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines. Prostate 42 1 (2000) 1-7
9. Chung J.H., Han J.H., Hwang E.J., Seo J.Y., Cho K.H., Kim K.H., Youn J.I., and Eun H.C. Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. Faseb J. 17 13 (2003) 1913-1915
10. Crowe D.L., Tsang K.J., and Shemirani B. Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression. Neoplasia 3 1 (2001) 27-32
11. Curran S., and Murray G.I. Matrix metalloproteinases in tumour invasion and metastasis. J. Pathol. 189 3 (1999) 300-308
12. Deeble P.D., Murphy D.J., Parsons S.J., and Cox M.E. Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells. Molec. Cell. Biol. 21 24 (2001) 8471-8482
13. Fagot D., Asselineau D., and Bernerd F. Direct role of human dermal fibroblasts and indirect participation of epidermal keratinocytes in MMP-1 production after UV-B irradiation. Arch. Dermatol. Res. 293 11 (2002) 576-583
14. Fisher G.J., Wang Z.Q., Datta S.C., Varani J., Kang S., and Voorhees J.J. Pathophysiology of premature skin aging induced by ultraviolet light. N. Engl. J. Med. 337 20 (1997) 1419-1428
15. Fukuda K., Hibiya Y., Mutoh M., Koshiji M., Akao S., and Fujiwara H. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J. Ethnopharmacol. 66 2 (1999) 227-233
16. Fukuda K., Hibiya Y., Mutoh M., Koshiji M., Akao S., and Fujiwara H. Inhibition of activator protein 1 activity by berberine in human hepatoma cells. Planta Med. 65 4 (1999) 381-383
17. Himelstein B.P., Lee E.J., Sato H., Seiki M., and Muschel R.J. Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat. Clin. Exp. Metastasis 16 2 (1998) 169-177
18. Ikram M. A review on the chemical and pharmacological aspects of genus Berberis. Planta Med. 28 4 (1975) 353-358
19. Kahari V.M., and Saarialho-Kere U. Matrix metalloproteinases in skin. Exp. Dermatol. 6 5 (1997) 199-213
20. Kuo C.L., Chou C.C., and Yung B.Y. Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett. 93 2 (1995) 193-200
21. Lin T., Zhang W., Fan Y., and Mulholland M. Interleukin-1beta and interleukin-6 stimulate matrix metalloproteinase-9 secretion in cultured myenteric glia. J. Surg. Res. 137 1 (2007) 38-45
22. MacDougall J.R., and Matrisian L.M. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14 4 (1995) 351-362
23. Mook O.R., Frederiks W.M., and Van Noorden C.J. The role of gelatinases in colorectal cancer progression and metastasis. Biochim. Biophys. Acta 1705 2 (2004) 69-89
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 1-2 (1983) 55-63
25. Onoue S., Kobayashi T., Takemoto Y., Sasaki I., and Shinkai H. Induction of matrix metalloproteinase-9 secretion from human keratinocytes in culture by ultraviolet B irradiation. J. Dermatol. Sci. 33 2 (2003) 105-111
26. Park C.H., Lee M.J., Ahn J., Kim S., Kim H.H., Kim K.H., Eun H.C., and Chung J.H. Heat shock-induced matrix metalloproteinase (MMP)-1 and MMP-3 are mediated through ERK and JNK activation and via an autocrine interleukin-6 loop. J. Invest. Dermatol. 123 6 (2004) 1012-1019
27. Schuringa J.J., Timmer H., Luttickhuizen D., Vellenga E., and Kruijer W. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 response element (IRE). Cytokine 14 2 (2001) 78-87
28. Simon C., Simon M., Vucelic G., Hicks M.J., Plinkert P.K., Koitschev A., and Zenner H.P. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp. Cell Res. 271 2 (2001) 344-355
29. Steinbrenner H., Ramos M.C., Stuhlmann D., Sies H., and Brenneisen P. UVA-mediated downregulation of MMP-2 and MMP-9 in human epidermal keratinocytes. Biochem. Biophys. Res. Commun. 308 3 (2003) 486-491
30. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91 4 (1997) 439-442
31. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. Faseb J. 13 8 (1999) 781-792
32. Zeigler M.E., Chi Y., Schmidt T., and Varani J. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J. Cell. Physiol. 180 2 (1999) 271-284
33. Zeng Z.S., and Guillem J.G. Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells. Br. J. Cancer 74 8 (1996) 1161-1167